Cargando…
The danger of diazoxide in the neonatal intensive care unit
BACKGROUND: The most common cause of persistent hypoglycemia in infancy is hyperinsulinemic hypoglycemia. When conservative measures fail, providers often use medications to treat persistent hypoglycemia. Diazoxide is first-line therapy for neonatal hypoglycemia and works by inhibiting insulin secre...
Autores principales: | Desai, Jay, Key, Logan, Swindall, Alyson, Gaston, Kan, Talati, Ajay J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135194/ https://www.ncbi.nlm.nih.gov/pubmed/34046157 http://dx.doi.org/10.1177/20420986211011338 |
Ejemplares similares
-
Prevalence and safety of diazoxide in the neonatal intensive care unit
por: Gray, Keyaria D, et al.
Publicado: (2018) -
Trends of Staphylococcus aureus bloodstream infections in a neonatal intensive care unit from 2000-2009
por: Dolapo, Olajide, et al.
Publicado: (2014) -
Diazoxide for Neonatal Hyperinsulinemic Hypoglycemia and Pulmonary Hypertension
por: Newman-Lindsay, Shoshana, et al.
Publicado: (2022) -
Diazoxide-Induced Hypertrichosis in a Neonate With Transient
Hyperinsulinism
por: Boskabadi, Seyyed Javad, et al.
Publicado: (2023) -
Necrotizing enterocolitis following diazoxide therapy for persistent neonatal hypoglycemia
por: Theodorou, Christina M., et al.
Publicado: (2019)